Helmerich & Payne (HP) Financials

$39.88 0.00 (-0.01%)

Closing price 05/22/2026 03:59 PM Eastern

Extended Trading

$39.62 -0.26 (-0.66%)

As of 05/22/2026 07:02 PM Eastern

Annual Income Statements for Helmerich & Payne

This table shows Helmerich & Payne's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	420	-57	-128	483	-34	-494	-326	6.95	434	344	-164
Consolidated Net Income / (Loss)	420	-57	-128	483	-34	-494	-326	6.95	434	344	-160
Net Income / (Loss) Continuing Operations	420	-53	-128	493	-33	-496	-326	6.95	434	344	-160
Total Pre-Tax Income	662	-73	-185	16	-51	-636	-430	31	593	481	-74
Total Operating Income	672	-26	-169	33	21	-620	-429	45	568	457	3.32
Total Gross Profit	1,458	725	555	835	995	583	261	628	1,159	1,127	1,179
Total Revenue	3,162	1,624	1,805	2,487	2,798	1,774	1,219	2,059	2,872	2,757	3,746
Operating Revenue	3,162	1,624	1,805	2,487	2,798	1,774	1,219	2,059	2,872	2,757	3,746
Total Cost of Revenue	1,703	899	1,249	1,653	1,803	1,191	958	1,431	1,713	1,629	2,567
Operating Cost of Revenue	1,703	893	1,245	1,648	1,803	1,185	953	1,427	1,709	1,625	2,511
Other Cost of Revenue	-	6.06	4.58	5.05	-	5.78	5.14	4.64	4.48	4.48	56
Total Operating Expenses	786	751	725	802	975	1,204	689	582	591	670	1,175
Selling, General & Admin Expense	135	146	148	199	194	168	172	182	207	245	287
Research & Development Expense	16	10	12	18	27	22	22	27	30	41	34
Depreciation Expense	608	599	586	584	563	482	420	403	382	397	625
Other Operating Expenses / (Income)	-	-	-	-	5.38	-27	-12	-29	-48	-33	-33
Impairment Charge	39	6.25	0.00	23	224	563	71	4.36	12	0.00	194
Restructuring Charge	-	-	-	0.00	0.00	16	5.93	0.84	0.00	15	67
Other Special Charges / (Income)	-12	-9.90	-21	-23	-40	-20	11	-5.43	8.02	5.14	1.54
Total Other Income / (Expense), net	-10	-47	-16	-17	-72	-16	-1.32	-14	25	24	-77
Interest Expense	15	23	20	24	25	24	24	79	17	29	108
Interest & Investment Income	5.84	-23	5.92	8.02	-45	14	17	76	40	55	13
Other Income / (Expense), net	-0.90	-0.97	-1.68	-0.88	-1.60	-5.38	5.65	-11	2.66	-2.46	18
Income Tax Expense	241	-20	-57	-477	-19	-140	-104	24	159	137	86
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	-	-	0.00	0.00	3.75
Basic Earnings per Share	$3.88	($0.54)	($1.20)	$4.39	($0.34)	($4.60)	($3.04)	$0.05	$4.18	$3.43	($1.66)
Weighted Average Basic Shares Outstanding	107.75M	108.00M	108.50M	108.85M	109.22M	108.01M	107.82M	105.89M	102.45M	98.86M	99.27M
Diluted Earnings per Share	$3.85	($0.54)	($1.20)	$4.37	($0.34)	($4.60)	($3.04)	$0.05	$4.16	$3.43	($1.66)
Weighted Average Diluted Shares Outstanding	108.57M	108.00M	108.50M	109.39M	109.22M	108.01M	107.82M	106.56M	102.85M	99.07M	99.27M
Weighted Average Basic & Diluted Shares Outstanding	108.40M	105.20M	106.80M	109.90M	108.45M	107.60M	108.00M	105.39M	99.43M	98.76M	98.45M
Cash Dividends to Common per Share	$2.75	$2.78	$2.80	$2.82	$2.84	$1.92	$1.00	$1.00	-	$0.25	$0.25

This table shows Helmerich & Payne's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	78	95	85	89	75	55	1.65	-163	-57	-97	-59
Consolidated Net Income / (Loss)	78	95	85	89	75	55	2.99	-162	-56	-95	-56
Net Income / (Loss) Continuing Operations	78	95	85	89	75	55	2.99	-162	-56	-95	-56
Total Pre-Tax Income	113	125	117	122	116	76	44	-133	-62	-84	-47
Total Operating Income	94	123	111	113	107	91	42	-128	-0.56	-60	-37
Total Gross Profit	250	273	286	282	285	265	311	306	298	303	246
Total Revenue	660	677	688	698	694	677	1,016	1,041	1,012	1,017	932
Operating Revenue	660	677	688	698	694	677	1,016	1,041	1,012	1,017	932
Total Cost of Revenue	410	404	402	416	409	412	705	735	714	714	686
Operating Cost of Revenue	409	403	401	415	408	411	702	704	694	683	661
Other Cost of Revenue	1.16	1.14	1.03	1.14	1.18	1.16	3.49	31	20	31	25
Total Operating Expenses	156	149	174	168	178	174	269	434	298	363	283
Selling, General & Admin Expense	56	57	61	60	59	63	81	66	78	70	71
Research & Development Expense	7.33	8.61	13	11	8.86	9.36	9.42	7.78	7.57	6.65	7.02
Depreciation Expense	95	94	105	98	101	99	158	179	189	182	181
Other Operating Expenses / (Income)	-10	-7.49	-7.46	-9.73	-8.62	-9.40	-9.97	-6.77	-7.25	-6.12	-5.94
Impairment Charge	-	-	0.00	0.00	-	0.00	1.84	173	-	103	26
Restructuring Charge	-	0.00	0.85	6.68	-	11	30	13	13	5.00	5.62
Other Special Charges / (Income)	8.41	-2.44	2.43	2.73	2.42	1.67	-0.88	1.35	-0.60	1.93	-1.31
Total Other Income / (Expense), net	19	1.79	5.86	8.93	9.81	-14	2.29	-4.64	-62	-24	-9.64
Interest Expense	4.37	4.37	4.26	4.34	16	22	28	29	28	26	26
Interest & Investment Income	13	6.70	10	12	26	8.37	35	2.52	-33	3.69	17
Other Income / (Expense), net	10	-0.54	-0.20	0.99	0.10	-0.55	-4.42	22	-0.43	-1.90	-0.38
Income Tax Expense	35	30	32	34	41	22	41	29	-6.27	11	9.30
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	0.00	0.00	-	0.00	1.33	0.86	-	1.78	2.75
Basic Earnings per Share	$0.78	$0.95	$0.85	$0.89	$0.74	$0.55	$0.01	($1.64)	($0.58)	($0.98)	($0.59)
Weighted Average Basic Shares Outstanding	102.45M	99.14M	98.77M	98.75M	98.86M	98.87M	99.36M	99.42M	99.27M	99.54M	99.88M
Diluted Earnings per Share	$0.77	$0.94	$0.84	$0.88	$0.77	$0.54	$0.01	($1.64)	($0.57)	($0.98)	($0.59)
Weighted Average Diluted Shares Outstanding	102.85M	99.63M	99.05M	99.01M	99.07M	99.16M	99.38M	99.42M	99.27M	99.54M	99.88M
Weighted Average Basic & Diluted Shares Outstanding	99.43M	98.83M	98.72M	98.76M	98.76M	99.38M	99.42M	99.44M	98.45M	99.85M	99.93M

This table details how cash moves in and out of Helmerich & Payne's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	369	176	-375	-234	57	154	400	-668	47	1,212	-1,303
Net Cash From Operating Activities	1,429	755	371	558	856	539	136	234	834	685	543
Net Cash From Continuing Operating Activities	1,429	754	371	558	856	539	136	234	834	685	543
Net Income / (Loss) Continuing Operations	420	-53	-128	493	-33	-496	-326	6.95	434	344	-160
Consolidated Net Income / (Loss)	420	-57	-128	483	-34	-494	-326	6.95	434	344	-160
Depreciation Expense	608	599	586	584	563	482	420	403	382	397	625
Amortization Expense	0.75	1.17	1.06	1.07	1.73	1.82	1.42	1.20	1.08	11	6.07
Non-Cash Adjustments To Reconcile Net Income	61	50	9.76	42	280	546	94	6.81	2.08	-5.79	230
Changes in Operating Assets and Liabilities, net	338	158	-97	-562	44	5.29	-52	-184	14	-62	-158
Net Cash From Investing Activities	-1,154	-234	-445	-472	-423	-88	-162	-167	-323	-459	-1,925
Net Cash From Continuing Investing Activities	-1,154	-234	-445	-472	-423	-88	-162	-167	-323	-459	-1,925
Purchase of Property, Plant & Equipment	-1,131	-257	-398	-467	-458	-141	-82	-273	-395	-495	-426
Acquisitions	0.00	0.00	-70	-48	-16	-	-	-	0.00	0.00	-1,836
Purchase of Investments	-46	-57	-70	-71	-98	-135	-418	-216	-202	-210	-120
Sale of Property, Plant & Equipment	23	22	23	44	51	78	130	62	70	46	46
Sale and/or Maturity of Investments	0.00	58	69	69	99	95	208	267	195	204	410
Other Investing Activities, net	-	-	-	0.00	0.00	0.00	0.00	-7.50	9.22	-4.47	1.34
Net Cash From Financing Activities	95	-344	-301	-320	-376	-297	426	-734	-464	987	67
Net Cash From Continuing Financing Activities	95	-344	-301	-320	-376	-297	426	-734	-464	987	67
Repayment of Debt	-46	-41	0.00	0.00	-17	-0.45	-4.65	-488	-0.54	-23	-206
Repurchase of Common Equity	-60	-	0.00	0.00	-43	-29	0.00	-77	-247	-51	0.00
Payment of Dividends	-298	-300	-306	-308	-313	-260	-109	-107	-201	-168	-116
Issuance of Debt	498	-	-	-	0.00	0.00	549	0.00	0.00	1,248	400
Other Financing Activities, net	1.28	-2.87	4.69	-11	-3.37	-7.93	-9.41	-62	-15	-18	-11
Effect of Exchange Rate Changes	-	-	-	-	-	-	-	-	0.00	0.00	13
Cash Interest Paid	-	28	23	21	27	23	27	19	17	16	82
Cash Income Taxes Paid	-	-24	-23	-38	16	47	1.46	18	199	181	206

This table details how cash moves in and out of Helmerich & Payne's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	34	-37	-17	20	1,247	178	-1,461	-18	-1.23	54	-75
Net Cash From Operating Activities	215	175	144	197	169	158	56	122	207	182	37
Net Cash From Continuing Operating Activities	215	175	144	197	169	158	56	122	207	182	37
Net Income / (Loss) Continuing Operations	78	95	85	89	75	55	2.99	-162	-56	-95	-56
Consolidated Net Income / (Loss)	78	95	85	89	75	55	2.99	-162	-56	-95	-56
Depreciation Expense	95	94	105	98	101	99	158	179	189	182	181
Amortization Expense	-	0.15	-	-	-	2.39	1.07	1.34	1.27	1.25	1.28
Non-Cash Adjustments To Reconcile Net Income	4.43	2.07	0.92	1.36	-10	12	-26	180	65	105	13
Changes in Operating Assets and Liabilities, net	37	-17	-47	9.53	-7.98	-9.99	-79	-77	8.12	-11	-103
Net Cash From Investing Activities	-132	-113	-111	-130	-105	53	-1,868	-57	-53	-58	-54
Net Cash From Continuing Investing Activities	-132	-113	-111	-130	-105	53	-1,868	-57	-53	-58	-54
Purchase of Property, Plant & Equipment	-114	-136	-118	-134	-106	-106	-159	-97	-64	-68	-63
Purchase of Investments	-81	-47	-36	-75	-52	-97	-7.37	-9.76	-6.62	-18	-18
Sale of Property, Plant & Equipment	7.04	12	8.97	14	11	12	14	8.83	11	11	11
Sale and/or Maturity of Investments	47	58	29	65	52	243	121	41	5.33	17	17
Other Investing Activities, net	9.22	0.00	-	0.55	-10	0.70	1.67	-	-1.03	-0.37	-0.31
Net Cash From Financing Activities	-49	-99	-49	-48	1,183	-33	344	-90	-154	-70	-58
Net Cash From Continuing Financing Activities	-49	-99	-49	-48	1,183	-33	344	-90	-154	-70	-58
Repayment of Debt	-	0.00	-	0.25	-23	-1.22	-27	-50	-129	-32	-32
Payment of Dividends	-49	-42	-42	-42	-42	-25	-25	-41	-25	-32	-26
Other Financing Activities, net	-	-9.07	-3.11	-6.25	-0.00	-6.91	-3.69	-0.15	-0.08	-5.84	-0.32
Effect of Exchange Rate Changes	-	-	-	-	-	0.00	-	7.92	-1.35	-0.74	0.27
Cash Interest Paid	8.14	0.93	7.12	0.10	7.80	0.00	14	53	15	36	16
Cash Income Taxes Paid	43	5.96	75	58	42	4.28	97	64	41	17	29

This table presents Helmerich & Payne's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	7,147	6,832	6,440	6,215	5,840	4,830	5,034	4,356	4,382	5,782	6,706
Total Current Assets	1,439	1,573	1,235	1,116	1,115	963	1,587	1,003	1,007	1,192	1,465
Cash & Equivalents	729	906	521	284	348	488	918	232	257	217	197
Restricted Cash	-	-	-	-	-	-	18	36	59	69	27
Short-Term Investments	46	44	44	41	53	89	199	117	94	293	21
Accounts Receivable	446	375	477	565	496	193	229	459	404	419	783
Inventories, net	129	124	137	158	150	104	84	88	94	118	324
Prepaid Expenses	64	78	55	66	69	89	68	66	98	76	98
Other Current Assets	0.00	45	-	-	-	0.00	71	4.33	0.65	0.00	15
Plant, Property, & Equipment, net	5,563	5,145	5,001	4,857	4,502	3,646	3,127	2,961	2,922	3,016	4,313
Total Noncurrent Assets	145	115	204	242	222	220	320	392	454	1,574	927
Long-Term Investments	104	85	84	99	32	32	135	219	265	101	68
Goodwill	-	4.72	52	65	83	46	46	46	46	46	183
Intangible Assets	-	0.92	51	73	87	81	74	67	61	54	486
Other Noncurrent Operating Assets	41	24	17	5.26	21	62	65	60	82	1,373	191
Total Liabilities & Shareholders' Equity	7,147	6,832	6,440	6,215	5,840	4,830	5,034	4,356	4,382	5,782	6,706
Total Liabilities	2,251	2,271	2,271	1,832	1,827	1,511	2,122	1,590	1,610	2,865	3,876
Total Current Liabilities	348	330	344	377	410	219	866	395	419	447	815
Short-Term Debt	39	-	-	-	-	0.00	483	-	-	0.00	6.86
Accounts Payable	108	95	136	133	45	36	72	127	131	135	218
Accrued Expenses	198	235	209	245	287	155	283	241	263	287	565
Dividends Payable	-	-	-	-	78	27	27	27	25	25	25
Total Noncurrent Liabilities	1,903	1,941	1,927	1,455	1,417	1,292	1,255	1,195	1,191	2,418	3,062
Long-Term Debt	492	492	493	494	479	481	542	543	545	1,782	2,057
Noncurrent Deferred & Payable Income Tax Liabilities	1,296	1,342	1,333	853	807	651	563	538	518	495	624
Noncurrent Employee Benefit Liabilities	-	-	-	-	-	-	-	-	-	6.52	110
Other Noncurrent Operating Liabilities	110	103	101	94	116	147	148	115	128	134	271
Commitments & Contingencies	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	4,896	4,561	4,165	4,383	4,012	3,319	2,913	2,765	2,772	2,917	2,829
Total Preferred & Common Equity	4,896	4,561	4,165	4,383	4,012	3,319	2,913	2,765	2,772	2,917	2,725
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,896	4,561	4,165	4,383	4,012	3,319	2,913	2,765	2,772	2,917	2,725
Common Stock	431	460	498	512	522	533	541	540	537	529	524
Retained Earnings	4,648	4,290	3,856	4,028	3,714	3,010	2,573	2,474	2,708	2,884	2,619
Treasury Stock	-182	-188	-192	-173	-195	-198	-182	-236	-464	-489	-464
Accumulated Other Comprehensive Income / (Loss)	-1.38	-0.20	2.30	17	-29	-26	-20	-12	-7.98	-6.35	45
Noncontrolling Interest	-	-	-	-	-	-	-	-	-	0.00	105

This table presents Helmerich & Payne's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026
Period end date	12/31/2022	3/31/2023	6/30/2023	12/31/2023	3/31/2024	6/30/2024	12/31/2024	3/31/2025	6/30/2025	12/31/2025	3/31/2026
Total Assets	4,412	4,366	4,341	4,421	4,425	4,485	5,817	7,242	6,862	6,459	6,336
Total Current Assets	1,079	1,004	993	989	949	970	1,225	1,493	1,491	1,462	1,473
Cash & Equivalents	229	160	221	214	194	204	391	175	166	247	177
Restricted Cash	42	53	61	65	69	78	73	69	59	31	26
Short-Term Investments	118	85	73	84	83	86	135	21	21	22	22
Accounts Receivable	513	526	450	436	432	415	427	786	783	727	811
Inventories, net	91	99	101	101	107	115	127	322	330	325	331
Prepaid Expenses	84	80	86	88	64	72	71	121	117	85	82
Other Current Assets	1.55	1.35	0.99	0.00	0.00	0.00	-	-	14	26	25
Plant, Property, & Equipment, net	2,942	2,931	2,933	2,970	2,994	3,014	3,009	4,485	4,408	4,100	3,977
Total Noncurrent Assets	391	430	415	462	482	500	1,582	1,264	963	897	886
Long-Term Investments	221	262	246	263	274	292	102	132	102	71	86
Goodwill	46	46	46	46	46	46	46	344	167	183	184
Intangible Assets	65	64	62	59	57	56	53	511	494	463	444
Other Noncurrent Operating Assets	59	59	62	94	105	107	1,383	277	201	180	173
Total Liabilities & Shareholders' Equity	4,412	4,366	4,341	4,421	4,425	4,485	5,817	7,242	6,862	6,459	6,336
Total Liabilities	1,667	1,610	1,633	1,662	1,622	1,628	2,870	4,190	3,995	3,757	3,706
Total Current Liabilities	470	414	433	469	439	457	436	888	810	722	863
Short-Term Debt	-	-	-	-	-	-	-	6.76	6.86	6.86	146
Accounts Payable	146	160	152	157	158	159	149	273	241	188	177
Accrued Expenses	272	203	233	270	238	256	262	583	537	501	514
Dividends Payable	52	50	49	42	42	42	25	25	25	25	25
Total Noncurrent Liabilities	1,197	1,196	1,199	1,193	1,183	1,171	2,434	3,302	3,186	3,035	2,843
Long-Term Debt	543	543	545	545	545	546	1,782	2,234	2,185	2,026	1,856
Noncurrent Deferred & Payable Income Tax Liabilities	537	540	541	510	502	494	486	646	615	631	618
Noncurrent Employee Benefit Liabilities	-	-	-	-	-	-	-	108	120	105	100
Other Noncurrent Operating Liabilities	116	113	113	137	135	131	167	314	266	273	269
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,745	2,756	2,708	2,760	2,803	2,857	2,947	3,052	2,867	2,702	2,630
Total Preferred & Common Equity	2,745	2,756	2,708	2,760	2,803	2,857	2,947	2,935	2,764	2,603	2,529
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	2,745	2,756	2,708	2,760	2,803	2,857	2,947	2,935	2,764	2,603	2,529
Common Stock	524	520	528	518	514	522	513	509	517	511	518
Retained Earnings	2,494	2,608	2,655	2,744	2,786	2,833	2,913	2,890	2,702	2,497	2,413
Treasury Stock	-261	-361	-464	-494	-490	-489	-473	-465	-464	-448	-445
Accumulated Other Comprehensive Income / (Loss)	-12	-12	-11	-7.85	-7.71	-8.50	-5.99	1.06	9.50	43	43
Noncontrolling Interest	-	-	-	-	-	-	-	117	103	99	101

This table displays calculated financial ratios and metrics derived from Helmerich & Payne's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	9/30/2015	9/30/2016	9/30/2017	9/30/2018	9/30/2019	9/30/2020	9/30/2021	9/30/2022	9/30/2023	9/30/2024	9/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.92%	-48.63%	11.11%	37.82%	12.51%	-36.61%	-31.31%	68.96%	39.51%	-4.03%	35.89%
EBITDA Growth	-18.82%	-55.24%	-27.41%	48.37%	-5.42%	-124.31%	98.77%	25,211.44%	117.42%	-9.58%	-24.44%
EBIT Growth	-36.24%	-104.01%	-534.09%	118.79%	-40.83%	-3,394.91%	32.40%	108.18%	1,551.25%	-20.31%	-95.41%
NOPAT Growth	-37.21%	-104.26%	-551.19%	966.77%	-98.60%	-3,113.25%	30.90%	103.35%	3,988.11%	-21.34%	-99.29%
Net Income Growth	-40.50%	-113.52%	-125.61%	476.46%	-106.97%	-1,369.27%	34.04%	102.13%	6,143.35%	-20.72%	-146.47%
EPS Growth	-40.22%	-114.03%	-122.22%	464.17%	-107.78%	-1,252.94%	33.91%	101.64%	8,220.00%	-17.55%	-148.40%
Operating Cash Flow Growth	26.53%	-47.18%	-50.80%	50.28%	53.40%	-37.03%	-74.68%	71.44%	256.41%	-17.87%	-20.70%
Free Cash Flow Firm Growth	38.12%	102.09%	-121.26%	628.88%	-42.38%	47.88%	-51.98%	-109.78%	2,174.53%	-322.38%	46.89%
Invested Capital Growth	4.01%	-11.57%	-0.26%	11.34%	-7.04%	-22.18%	-16.52%	1.22%	-2.30%	51.63%	13.84%
Revenue Q/Q Growth	-11.91%	-12.03%	12.50%	7.08%	-1.68%	-19.90%	12.51%	16.23%	0.99%	1.26%	9.28%
EBITDA Q/Q Growth	-17.02%	-10.53%	12.12%	8.27%	0.03%	-15,593.47%	-110.18%	53.83%	3.51%	2.32%	-4.20%
EBIT Q/Q Growth	-29.96%	-163.83%	28.28%	272.23%	414.94%	-22.66%	-2.73%	128.34%	6.68%	0.58%	-83.76%
NOPAT Q/Q Growth	-30.94%	-31.34%	28.31%	8,488.27%	256.46%	-22.63%	-5.31%	111.17%	3.90%	1.51%	107.85%
Net Income Q/Q Growth	-31.59%	-390.36%	28.18%	5.46%	53.50%	-25.39%	-6.60%	105.91%	7.98%	-0.62%	-457.99%
EPS Q/Q Growth	-31.37%	-390.91%	28.14%	5.56%	50.00%	-25.00%	-5.92%	104.55%	9.19%	0.00%	-418.75%
Operating Cash Flow Q/Q Growth	-3.65%	-15.45%	-2.16%	11.04%	1.18%	-16.14%	-25.22%	43.28%	13.23%	-6.29%	7.57%
Free Cash Flow Firm Q/Q Growth	78.62%	8.76%	-170.06%	223.24%	-2.89%	16.65%	21.35%	-129.59%	5.06%	-547.14%	71.84%
Invested Capital Q/Q Growth	-2.45%	-3.81%	-1.10%	-0.91%	-0.50%	-5.01%	-7.75%	-0.96%	-1.25%	45.27%	-2.74%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	46.12%	44.66%	30.78%	33.56%	35.57%	32.89%	21.40%	30.49%	40.14%	40.70%	31.46%
EBITDA Margin	40.48%	35.27%	23.04%	24.80%	20.85%	-8.00%	-0.14%	21.32%	33.23%	31.30%	17.41%
Operating Margin	21.25%	-1.60%	-9.37%	1.33%	0.74%	-34.96%	-35.17%	2.20%	19.56%	16.39%	0.09%
EBIT Margin	21.22%	-1.66%	-9.46%	1.29%	0.68%	-35.26%	-34.70%	1.68%	19.88%	16.51%	0.56%
Profit (Net Income) Margin	13.30%	-3.50%	-7.10%	19.41%	-1.20%	-27.88%	-26.77%	0.34%	15.11%	12.49%	-4.27%
Tax Burden Percent	63.52%	78.20%	69.45%	3,046.98%	65.71%	77.69%	75.87%	22.20%	73.16%	71.55%	215.82%
Interest Burden Percent	98.63%	269.83%	108.10%	49.37%	-269.79%	101.75%	101.65%	90.57%	103.92%	105.72%	-355.20%
Effective Tax Rate	36.47%	0.00%	0.00%	-3,012.24%	0.00%	0.00%	0.00%	77.80%	26.84%	28.45%	0.00%
Return on Invested Capital (ROIC)	9.57%	-0.42%	-2.95%	24.20%	0.33%	-11.76%	-10.12%	0.37%	15.23%	9.63%	0.05%
ROIC Less NNEP Spread (ROIC-NNEP)	11.06%	8.29%	-0.10%	1,592.74%	-42.72%	-243.47%	7.17%	2.85%	-17.77%	13.71%	-11.13%
Return on Net Nonoperating Assets (RNNOA)	-0.98%	-0.78%	0.01%	-12.91%	-1.14%	-1.73%	-0.35%	-0.13%	0.45%	2.46%	-5.62%
Return on Equity (ROE)	8.59%	-1.20%	-2.94%	11.29%	-0.80%	-13.49%	-10.47%	0.24%	15.68%	12.10%	-5.57%
Cash Return on Invested Capital (CROIC)	5.64%	11.85%	-2.69%	13.47%	7.64%	13.18%	7.88%	-0.84%	17.56%	-31.40%	-12.89%
Operating Return on Assets (OROA)	9.68%	-0.39%	-2.57%	0.51%	0.32%	-11.73%	-8.57%	0.74%	13.07%	8.95%	0.33%
Return on Assets (ROA)	6.06%	-0.81%	-1.93%	7.63%	-0.56%	-9.27%	-6.61%	0.15%	9.94%	6.77%	-2.56%
Return on Common Equity (ROCE)	8.59%	-1.20%	-2.94%	11.29%	-0.80%	-13.49%	-10.47%	0.24%	15.68%	12.10%	-5.47%
Return on Equity Simple (ROE_SIMPLE)	8.59%	-1.25%	-3.08%	11.01%	-0.84%	-14.90%	-11.20%	0.25%	15.66%	11.80%	0.00%
Net Operating Profit after Tax (NOPAT)	427	-18	-118	1,026	14	-434	-300	10	411	323	2.32
NOPAT Margin	13.50%	-1.12%	-6.56%	41.25%	0.51%	-24.47%	-24.62%	0.49%	14.31%	11.73%	0.06%
Net Nonoperating Expense Percent (NNEP)	-1.49%	-8.72%	-2.85%	-1,568.54%	43.05%	231.71%	-17.29%	-2.48%	33.00%	-4.07%	11.18%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	0.05%
Cost of Revenue to Revenue	53.88%	55.34%	69.22%	66.44%	64.43%	67.11%	78.60%	69.51%	59.87%	59.30%	68.54%
SG&A Expenses to Revenue	4.26%	9.00%	8.18%	8.01%	6.95%	9.44%	14.13%	8.86%	7.19%	8.88%	7.66%
R&D to Revenue	0.51%	0.63%	0.67%	0.73%	0.98%	1.22%	1.78%	1.29%	1.05%	1.49%	0.91%
Operating Expenses to Revenue	24.87%	46.26%	40.14%	32.23%	34.83%	67.85%	56.57%	28.29%	20.57%	24.31%	31.37%
Earnings before Interest and Taxes (EBIT)	671	-27	-171	32	19	-626	-423	35	571	455	21
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,280	573	416	617	584	-142	-1.75	439	954	863	652
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.66	1.07	0.96	1.26	0.85	0.40	0.90	1.28	1.44	1.03	0.80
Price to Tangible Book Value (P/TBV)	0.66	1.07	0.98	1.30	0.88	0.42	0.94	1.34	1.50	1.07	1.06
Price to Revenue (P/Rev)	1.03	3.00	2.21	2.21	1.21	0.75	2.15	1.72	1.39	1.09	0.58
Price to Earnings (P/E)	7.73	0.00	0.00	11.41	0.00	0.00	0.00	510.12	9.23	8.73	0.00
Dividend Yield	9.12%	6.13%	7.64%	5.56%	9.16%	19.14%	4.12%	2.97%	2.48%	4.14%	4.57%
Earnings Yield	12.94%	0.00%	0.00%	8.76%	0.00%	0.00%	0.00%	0.20%	10.84%	11.46%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.64	1.08	0.95	1.25	0.83	0.37	0.88	1.28	1.45	1.02	0.88
Enterprise Value to Revenue (EV/Rev)	0.92	2.67	2.12	2.24	1.23	0.68	1.95	1.69	1.35	1.49	1.08
Enterprise Value to EBITDA (EV/EBITDA)	2.27	7.56	9.19	9.04	5.90	0.00	0.00	7.94	4.06	4.76	6.18
Enterprise Value to EBIT (EV/EBIT)	4.32	0.00	0.00	173.78	181.25	0.00	0.00	100.79	6.79	9.03	193.21
Enterprise Value to NOPAT (EV/NOPAT)	6.79	0.00	0.00	5.44	238.85	0.00	0.00	346.59	9.43	12.70	1,735.67
Enterprise Value to Operating Cash Flow (EV/OCF)	2.03	5.74	10.30	10.00	4.02	2.24	17.39	14.90	4.65	6.00	7.42
Enterprise Value to Free Cash Flow (EV/FCFF)	11.54	8.52	0.00	9.76	10.46	2.48	10.15	0.00	8.18	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.11	0.11	0.12	0.11	0.12	0.14	0.35	0.20	0.20	0.61	0.73
Long-Term Debt to Equity	0.10	0.11	0.12	0.11	0.12	0.14	0.19	0.20	0.20	0.61	0.73
Financial Leverage	-0.09	-0.09	-0.08	-0.01	0.03	0.01	-0.05	-0.04	-0.03	0.18	0.51
Leverage Ratio	1.42	1.48	1.52	1.48	1.44	1.46	1.58	1.65	1.58	1.79	2.17
Compound Leverage Factor	1.40	3.99	1.64	0.73	-3.87	1.48	1.61	1.50	1.64	1.89	-7.72
Debt to Total Capital	9.79%	9.73%	10.58%	10.13%	10.67%	12.65%	26.04%	16.40%	16.43%	37.92%	42.18%
Short-Term Debt to Total Capital	0.72%	0.00%	0.00%	0.00%	0.00%	0.00%	12.28%	0.00%	0.00%	0.00%	0.14%
Long-Term Debt to Total Capital	9.07%	9.73%	10.58%	10.13%	10.67%	12.65%	13.76%	16.40%	16.43%	37.92%	42.04%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.14%
Common Equity to Total Capital	90.21%	90.27%	89.42%	89.87%	89.33%	87.35%	73.96%	83.60%	83.57%	62.08%	55.68%
Debt to EBITDA	0.42	0.86	1.19	0.80	0.82	-3.39	-586.66	1.24	0.57	2.07	3.17
Net Debt to EBITDA	-0.27	-0.95	-0.38	0.11	0.08	0.90	139.90	-0.14	-0.14	1.28	2.68
Long-Term Debt to EBITDA	0.38	0.86	1.19	0.80	0.82	-3.39	-310.07	1.24	0.57	2.07	3.15
Debt to NOPAT	1.25	-27.06	-4.16	0.48	33.27	-1.11	-3.42	53.96	1.33	5.51	888.63
Net Debt to NOPAT	-0.81	29.86	1.33	0.07	3.22	0.30	0.82	-6.15	-0.32	3.41	753.46
Long-Term Debt to NOPAT	1.15	-27.06	-4.16	0.48	33.27	-1.11	-1.81	53.96	1.33	5.51	885.68
Altman Z-Score	2.71	2.61	2.25	3.27	2.64	1.53	1.59	2.80	3.60	2.22	1.57
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.82%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	4.13	4.76	3.59	2.96	2.72	4.40	1.83	2.54	2.40	2.67	1.80
Quick Ratio	3.51	4.01	3.03	2.36	2.19	3.51	1.55	2.05	1.80	2.08	1.23
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	251	508	-108	571	329	487	234	-23	474	-1,054	-558
Operating Cash Flow to CapEx	128.84%	320.64%	99.21%	132.13%	209.96%	863.65%	0.00%	111.26%	256.22%	152.60%	142.66%
Free Cash Flow to Firm to Interest Expense	16.73	22.17	-5.47	23.54	13.06	19.88	9.75	-0.29	27.42	-36.22	-5.17
Operating Cash Flow to Interest Expense	95.09	32.93	18.80	22.99	33.97	22.02	5.70	2.95	48.24	23.53	5.04
Operating Cash Flow Less CapEx to Interest Expense	21.29	22.66	-0.15	5.59	17.79	19.47	7.69	0.30	29.41	8.11	1.51
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.46	0.23	0.27	0.39	0.46	0.33	0.25	0.44	0.66	0.54	0.60
Accounts Receivable Turnover	5.49	3.96	4.24	4.77	5.28	5.16	5.78	5.99	6.66	6.70	6.24
Inventory Turnover	14.51	7.11	9.55	11.19	11.72	9.38	10.18	16.64	18.88	15.41	11.61
Fixed Asset Turnover	0.59	0.30	0.36	0.50	0.60	0.44	0.36	0.68	0.98	0.93	1.02
Accounts Payable Turnover	11.74	8.83	10.81	12.32	20.26	29.09	17.66	14.39	13.34	12.29	14.55
Days Sales Outstanding (DSO)	66.45	92.26	86.18	76.48	69.18	70.80	63.13	60.95	54.82	54.47	58.52
Days Inventory Outstanding (DIO)	25.15	51.34	38.20	32.61	31.15	38.91	35.87	21.93	19.34	23.68	31.43
Days Payable Outstanding (DPO)	31.09	41.34	33.75	29.63	18.02	12.55	20.67	25.37	27.36	29.69	25.09
Cash Conversion Cycle (CCC)	60.51	102.27	90.63	79.46	82.31	97.17	78.33	57.51	46.80	48.46	64.86
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	4,548	4,022	4,012	4,466	4,152	3,231	2,697	2,730	2,667	4,045	4,605
Invested Capital Turnover	0.71	0.38	0.45	0.59	0.65	0.48	0.41	0.76	1.06	0.82	0.87
Increase / (Decrease) in Invested Capital	176	-526	-10	455	-315	-921	-534	33	-63	1,377	560
Enterprise Value (EV)	2,900	4,329	3,823	5,576	3,441	1,208	2,372	3,485	3,876	4,107	4,031
Market Capitalization	3,248	4,872	3,980	5,507	3,395	1,337	2,617	3,547	4,005	3,004	2,177
Book Value per Share	$45.44	$42.20	$38.35	$40.23	$36.66	$30.88	$26.99	$26.27	$27.88	$29.54	$27.40
Tangible Book Value per Share	$45.44	$42.15	$37.41	$38.96	$35.11	$29.70	$25.89	$25.19	$26.81	$28.53	$20.68
Total Capital	5,427	5,053	4,657	4,877	4,492	3,799	3,938	3,308	3,317	4,699	4,893
Total Debt	532	492	493	494	479	481	1,025	543	545	1,782	2,064
Total Long-Term Debt	492	492	493	494	479	481	542	543	545	1,782	2,057
Net Debt	-348	-543	-157	69	46	-128	-245	-62	-130	1,102	1,750
Capital Expenditures (CapEx)	1,109	235	374	422	408	62	-48	210	325	449	381
Debt-free, Cash-free Net Working Capital (DFCFNWC)	355	293	325	413	304	167	69	223	178	166	412
Debt-free Net Working Capital (DFNWC)	1,130	1,243	891	738	705	744	1,204	608	588	745	657
Net Working Capital (NWC)	1,091	1,243	891	738	705	744	720	608	588	745	651
Net Nonoperating Expense (NNE)	6.45	39	9.85	543	48	60	26	3.10	-23	-21	162
Net Nonoperating Obligations (NNO)	-348	-539	-153	84	140	-87	-215	-35	-104	1,127	1,775
Total Depreciation and Amortization (D&A)	609	600	587	585	565	484	421	404	383	408	631
Debt-free, Cash-free Net Working Capital to Revenue	11.23%	18.03%	18.01%	16.59%	10.86%	9.41%	5.68%	10.81%	6.19%	6.02%	10.99%
Debt-free Net Working Capital to Revenue	35.74%	76.50%	49.36%	29.69%	25.19%	41.95%	98.78%	29.54%	20.46%	27.03%	17.55%
Net Working Capital to Revenue	34.51%	76.50%	49.36%	29.69%	25.19%	41.95%	59.11%	29.54%	20.46%	27.03%	17.37%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$3.90	($0.54)	($1.20)	$4.39	($0.34)	($4.60)	($3.04)	$0.05	$4.18	$3.43	($1.66)
Adjusted Weighted Average Basic Shares Outstanding	107.75M	108.00M	108.50M	108.85M	109.22M	108.01M	107.82M	105.89M	102.45M	98.86M	99.27M
Adjusted Diluted Earnings per Share	$3.87	($0.54)	($1.20)	$4.37	($0.34)	($4.60)	($3.04)	$0.05	$4.16	$3.43	($1.66)
Adjusted Weighted Average Diluted Shares Outstanding	108.57M	108.00M	108.50M	109.39M	109.22M	108.01M	107.82M	106.56M	102.85M	99.07M	99.27M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	107.79M	108.18M	108.61M	109.04M	108.45M	107.60M	108.00M	105.39M	99.43M	98.76M	98.45M
Normalized Net Operating Profit after Tax (NOPAT)	444	-21	-133	23	144	-43	-238	32	426	338	186
Normalized NOPAT Margin	14.05%	-1.28%	-7.36%	0.94%	5.13%	-2.40%	-19.56%	1.53%	14.82%	12.25%	4.97%
Pre Tax Income Margin	20.93%	-4.47%	-10.23%	0.64%	-1.83%	-35.88%	-35.28%	1.52%	20.66%	17.45%	-1.98%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	44.67	-1.18	-8.65	1.32	0.75	-25.56	-17.65	0.44	33.04	15.64	0.19
NOPAT to Interest Expense	28.42	-0.79	-5.99	42.28	0.57	-17.74	-12.52	0.13	23.78	11.11	0.02
EBIT Less CapEx to Interest Expense	-29.14	-11.45	-27.60	-16.08	-15.43	-28.11	-15.65	-2.22	14.21	0.22	-3.34
NOPAT Less CapEx to Interest Expense	-45.39	-11.06	-24.94	24.88	-15.61	-20.29	-10.52	-2.52	4.96	-4.31	-3.51
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	70.97%	-528.18%	-238.29%	63.90%	-931.25%	-52.65%	-33.46%	1,544.59%	46.41%	48.95%	-72.60%
Augmented Payout Ratio	85.16%	-528.18%	-238.29%	63.90%	-1,058.36%	-58.41%	-33.46%	2,652.01%	103.36%	63.85%	-72.60%

This table displays calculated financial ratios and metrics derived from Helmerich & Payne's official financial filings.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	99,849,488.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	99,849,488.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-0.59
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	4.48%	-5.90%	-10.57%	-3.62%	5.18%	0.02%	47.69%	49.19%	45.83%	50.16%	-8.24%
EBITDA Growth	18.49%	-9.91%	-20.43%	-12.61%	4.55%	-11.63%	-8.90%	-64.88%	-13.14%	-36.73%	-26.34%
EBIT Growth	52.41%	-14.80%	-36.44%	-22.71%	2.53%	-26.51%	-65.99%	-192.82%	-100.93%	-168.42%	-198.82%
NOPAT Growth	34.97%	-13.26%	-39.99%	-22.63%	7.09%	-31.26%	-96.49%	-209.21%	-100.55%	-164.38%	-1,012.41%
Net Income Growth	70.45%	-2.03%	-48.29%	-6.93%	-2.76%	-42.45%	-96.48%	-282.56%	-173.94%	-273.32%	-1,970.76%
EPS Growth	83.33%	3.30%	-45.81%	-5.38%	0.00%	-42.55%	-98.81%	-286.36%	-174.03%	-281.48%	-6,000.00%
Operating Cash Flow Growth	83.06%	-5.71%	2.02%	-32.57%	-21.39%	-9.41%	-61.00%	-38.40%	22.63%	15.20%	-34.73%
Free Cash Flow Firm Growth	753.53%	12.64%	23.06%	-101.37%	-1,127.02%	-1,329.50%	-2,269.05%	-322,379.75%	57.11%	69.99%	125.52%
Invested Capital Growth	-2.30%	-0.34%	-0.66%	3.07%	51.63%	48.97%	77.64%	70.05%	13.84%	8.35%	-11.67%
Revenue Q/Q Growth	-8.89%	2.66%	1.59%	1.42%	-0.56%	-2.38%	50.01%	2.45%	-2.80%	0.52%	-8.32%
EBITDA Q/Q Growth	-18.23%	9.29%	-0.65%	-1.51%	-2.18%	-7.62%	2.43%	-62.03%	153.53%	-35.83%	19.25%
EBIT Q/Q Growth	-29.75%	18.18%	-9.72%	3.13%	-6.81%	-15.29%	-58.22%	-381.46%	99.07%	-6,130.85%	39.66%
NOPAT Q/Q Growth	-38.09%	45.36%	-14.56%	0.63%	-14.31%	-6.68%	-95.61%	-3,269.94%	99.56%	-10,617.53%	38.38%
Net Income Q/Q Growth	-18.54%	22.61%	-10.87%	4.54%	-14.89%	-27.43%	-94.55%	-5,521.94%	65.53%	-70.11%	41.16%
EPS Q/Q Growth	-17.20%	22.08%	-10.64%	4.76%	-12.50%	-29.87%	-98.15%	-16,500.00%	65.24%	-71.93%	39.80%
Operating Cash Flow Q/Q Growth	-26.67%	-18.58%	-17.78%	37.34%	-14.51%	-6.16%	-64.61%	116.96%	70.19%	-11.85%	-79.95%
Free Cash Flow Firm Q/Q Growth	-20.25%	-19.05%	-4.36%	-102.22%	-59,731.12%	3.09%	-69.46%	5.04%	72.53%	32.15%	244.22%
Invested Capital Q/Q Growth	-1.25%	1.97%	1.85%	0.49%	45.27%	0.19%	21.45%	-3.80%	-2.74%	-4.65%	-0.98%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	37.88%	40.27%	41.44%	40.07%	41.02%	39.02%	30.60%	29.36%	29.43%	29.79%	26.43%
EBITDA Margin	30.11%	32.06%	31.33%	30.42%	29.93%	28.32%	19.34%	7.17%	18.69%	11.93%	15.52%
Operating Margin	14.21%	18.23%	16.07%	15.95%	15.36%	13.29%	4.15%	-12.32%	-0.06%	-5.89%	-3.96%
EBIT Margin	15.77%	18.15%	16.13%	16.40%	15.37%	13.34%	3.71%	-10.21%	-0.10%	-6.08%	-4.00%
Profit (Net Income) Margin	11.77%	14.06%	12.33%	12.71%	10.88%	8.09%	0.29%	-15.55%	-5.52%	-9.33%	-5.99%
Tax Burden Percent	68.87%	75.98%	72.49%	72.46%	64.87%	71.67%	6.72%	121.81%	89.91%	113.38%	119.97%
Interest Burden Percent	108.36%	101.89%	105.45%	106.94%	109.10%	84.59%	117.77%	125.12%	6,257.26%	135.46%	124.85%
Effective Tax Rate	31.13%	24.02%	27.51%	27.54%	35.13%	28.33%	93.28%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	10.41%	14.39%	11.52%	11.47%	8.18%	7.75%	0.22%	-7.87%	-0.03%	-3.99%	-2.39%
ROIC Less NNEP Spread (ROIC-NNEP)	-8.33%	9.48%	1,431.17%	-8.73%	9.43%	5.93%	0.24%	-15.90%	-3.85%	-7.78%	-4.07%
Return on Net Nonoperating Assets (RNNOA)	0.21%	-0.10%	0.17%	0.12%	1.70%	1.11%	0.08%	-4.99%	-1.95%	-3.85%	-2.57%
Return on Equity (ROE)	10.62%	14.29%	11.69%	11.60%	9.88%	8.86%	0.30%	-12.85%	-1.98%	-7.84%	-4.96%
Cash Return on Invested Capital (CROIC)	17.56%	14.91%	12.99%	8.59%	-31.40%	-30.66%	-50.32%	-52.66%	-12.89%	-10.46%	8.97%
Operating Return on Assets (OROA)	10.37%	11.63%	10.09%	10.12%	8.34%	7.18%	1.96%	-6.17%	-0.06%	-4.05%	-2.36%
Return on Assets (ROA)	7.74%	9.01%	7.71%	7.84%	5.90%	4.36%	0.16%	-9.40%	-3.31%	-6.21%	-3.53%
Return on Common Equity (ROCE)	10.62%	14.29%	11.69%	11.60%	9.88%	8.86%	0.29%	-12.62%	-1.94%	-7.70%	-4.77%
Return on Equity Simple (ROE_SIMPLE)	0.00%	15.66%	12.59%	12.12%	0.00%	10.31%	7.56%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	65	94	80	81	69	64	2.83	-90	-0.39	-42	-26
NOPAT Margin	9.78%	13.85%	11.65%	11.56%	9.96%	9.52%	0.28%	-8.63%	-0.04%	-4.12%	-2.77%
Net Nonoperating Expense Percent (NNEP)	18.74%	4.91%	-1,419.65%	20.20%	-1.24%	1.82%	-0.02%	8.03%	3.82%	3.79%	1.67%
Return On Investment Capital (ROIC_SIMPLE)	-	2.84%	-	-	-	1.36%	0.05%	-1.78%	-0.01%	-0.89%	-0.56%
Cost of Revenue to Revenue	62.12%	59.73%	58.56%	59.93%	58.98%	60.98%	69.40%	70.64%	70.57%	70.21%	73.57%
SG&A Expenses to Revenue	8.50%	8.36%	9.02%	9.58%	8.56%	9.31%	7.95%	6.29%	7.68%	6.93%	7.62%
R&D to Revenue	1.11%	1.27%	1.88%	1.51%	1.28%	1.38%	0.93%	0.75%	0.75%	0.65%	0.75%
Operating Expenses to Revenue	23.68%	22.04%	25.36%	24.11%	25.66%	25.74%	26.45%	41.69%	29.49%	35.68%	30.39%
Earnings before Interest and Taxes (EBIT)	104	123	111	114	107	90	38	-106	-0.99	-62	-37
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	199	217	216	212	208	192	196	75	189	121	145
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.44	1.25	1.45	1.23	1.03	1.07	0.88	0.55	0.80	1.08	1.42
Price to Tangible Book Value (P/TBV)	1.50	1.30	1.50	1.28	1.07	1.11	1.25	0.72	1.06	1.44	1.89
Price to Revenue (P/Rev)	1.39	1.22	1.48	1.29	1.09	1.15	0.84	0.44	0.58	0.69	0.90
Price to Earnings (P/E)	9.23	7.99	11.51	10.18	8.73	10.41	11.77	0.00	0.00	0.00	0.00
Dividend Yield	2.48%	2.88%	2.24%	3.05%	4.14%	3.94%	5.13%	7.72%	4.57%	3.49%	2.78%
Earnings Yield	10.84%	12.51%	8.69%	9.82%	11.46%	9.61%	8.50%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	1.45	1.24	1.44	1.22	1.02	1.05	0.93	0.73	0.88	1.04	1.24
Enterprise Value to Revenue (EV/Rev)	1.35	1.19	1.45	1.25	1.49	1.54	1.48	1.01	1.08	1.12	1.35
Enterprise Value to EBITDA (EV/EBITDA)	4.06	3.63	4.56	4.04	4.76	5.06	5.57	5.07	6.18	7.88	10.18
Enterprise Value to EBIT (EV/EBIT)	6.79	6.14	8.20	7.54	9.03	10.04	13.05	26.87	193.21	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	9.43	8.50	11.64	10.71	12.70	14.43	21.13	0.00	1,735.67	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	4.65	4.10	4.83	4.67	6.00	6.35	7.85	6.84	7.42	8.09	9.85
Enterprise Value to Free Cash Flow (EV/FCFF)	8.18	8.30	11.05	14.47	0.00	0.00	0.00	0.00	0.00	0.00	12.97
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.20	0.20	0.19	0.19	0.61	0.60	0.73	0.76	0.73	0.75	0.76
Long-Term Debt to Equity	0.20	0.20	0.19	0.19	0.61	0.60	0.73	0.76	0.73	0.75	0.71
Financial Leverage	-0.03	-0.01	0.00	-0.01	0.18	0.19	0.31	0.31	0.51	0.49	0.63
Leverage Ratio	1.58	1.60	1.58	1.59	1.79	1.79	1.99	1.98	2.17	2.17	2.39
Compound Leverage Factor	1.71	1.64	1.67	1.70	1.95	1.52	2.35	2.48	135.98	2.94	2.98
Debt to Total Capital	16.43%	16.50%	16.29%	16.04%	37.92%	37.68%	42.33%	43.33%	42.18%	42.94%	43.23%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.13%	0.14%	0.14%	0.14%	3.16%
Long-Term Debt to Total Capital	16.43%	16.50%	16.29%	16.04%	37.92%	37.68%	42.20%	43.19%	42.04%	42.79%	40.07%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.22%	2.03%	2.14%	2.10%	2.18%
Common Equity to Total Capital	83.57%	83.50%	83.71%	83.96%	62.08%	62.32%	55.45%	54.64%	55.68%	54.97%	54.59%
Debt to EBITDA	0.57	0.59	0.62	0.65	2.07	2.13	2.74	3.22	3.17	3.50	3.78
Net Debt to EBITDA	-0.14	-0.09	-0.09	-0.14	1.28	1.29	2.25	2.71	2.68	2.86	3.19
Long-Term Debt to EBITDA	0.57	0.59	0.62	0.65	2.07	2.13	2.73	3.21	3.15	3.48	3.50
Debt to NOPAT	1.33	1.37	1.59	1.71	5.51	6.06	10.39	-74.07	888.63	-19.69	-12.63
Net Debt to NOPAT	-0.32	-0.21	-0.22	-0.36	3.41	3.67	8.55	-62.26	753.46	-16.11	-10.67
Long-Term Debt to NOPAT	1.33	1.37	1.59	1.71	5.51	6.06	10.36	-73.83	885.68	-19.63	-11.70
Altman Z-Score	3.25	2.99	3.23	3.01	2.02	2.05	1.47	1.35	1.56	1.73	1.84
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	2.00%	1.80%	1.82%	1.76%	3.84%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.40	2.11	2.16	2.12	2.67	2.81	1.68	1.84	1.80	2.03	1.71
Quick Ratio	1.80	1.57	1.62	1.54	2.08	2.19	1.11	1.20	1.23	1.38	1.17
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	127	103	99	-2.19	-1,308	-1,268	-2,148	-2,040	-560	-380	548
Operating Cash Flow to CapEx	201.33%	140.42%	131.45%	164.31%	178.18%	167.81%	38.71%	137.92%	388.36%	322.63%	70.24%
Free Cash Flow to Firm to Interest Expense	29.18	23.58	23.14	-0.50	-81.12	-56.85	-75.81	-69.86	-20.03	-14.85	21.24
Operating Cash Flow to Interest Expense	49.18	39.98	33.73	45.52	10.47	7.10	1.98	4.16	7.40	7.12	1.42
Operating Cash Flow Less CapEx to Interest Expense	24.75	11.51	8.07	17.82	4.59	2.87	-3.13	1.14	5.49	4.92	-0.60
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.66	0.64	0.63	0.62	0.54	0.54	0.53	0.60	0.60	0.67	0.59
Accounts Receivable Turnover	6.66	5.97	5.74	6.29	6.70	6.39	5.07	5.72	6.24	7.08	5.01
Inventory Turnover	18.88	17.64	15.94	15.10	15.41	14.37	9.08	10.17	11.61	12.69	8.74
Fixed Asset Turnover	0.98	0.96	0.93	0.92	0.93	0.92	0.82	0.92	1.02	1.15	0.95
Accounts Payable Turnover	13.34	11.18	10.35	10.53	12.29	10.74	9.03	11.33	14.55	17.03	12.67
Days Sales Outstanding (DSO)	54.82	61.17	63.56	57.99	54.47	57.11	72.06	63.78	58.52	51.54	72.82
Days Inventory Outstanding (DIO)	19.34	20.70	22.89	24.18	23.68	25.40	40.21	35.87	31.43	28.75	41.76
Days Payable Outstanding (DPO)	27.36	32.64	35.28	34.66	29.69	33.99	40.43	32.21	25.09	21.44	28.81
Cash Conversion Cycle (CCC)	46.80	49.22	51.18	47.50	48.46	48.52	71.85	67.45	64.86	58.85	85.77
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	2,667	2,720	2,771	2,784	4,045	4,052	4,922	4,734	4,605	4,390	4,347
Invested Capital Turnover	1.06	1.04	0.99	0.99	0.82	0.81	0.80	0.91	0.87	0.97	0.86
Increase / (Decrease) in Invested Capital	-63	-9.28	-18	83	1,377	1,332	2,151	1,950	560	338	-574
Enterprise Value (EV)	3,876	3,373	3,987	3,410	4,107	4,242	4,557	3,452	4,031	4,586	5,391
Market Capitalization	4,005	3,455	4,062	3,525	3,004	3,162	2,596	1,507	2,177	2,823	3,598
Book Value per Share	$27.88	$27.76	$28.36	$28.94	$29.54	$29.84	$29.53	$27.80	$27.40	$26.44	$25.33
Tangible Book Value per Share	$26.81	$26.70	$27.32	$27.91	$28.53	$28.84	$20.93	$21.16	$20.68	$19.88	$19.04
Total Capital	3,317	3,305	3,349	3,402	4,699	4,728	5,293	5,058	4,893	4,735	4,632
Total Debt	545	545	545	546	1,782	1,782	2,240	2,192	2,064	2,033	2,002
Total Long-Term Debt	545	545	545	546	1,782	1,782	2,234	2,185	2,057	2,026	1,856
Net Debt	-130	-82	-75	-115	1,102	1,080	1,844	1,842	1,750	1,663	1,692
Capital Expenditures (CapEx)	107	124	109	120	95	94	145	88	53	57	52
Debt-free, Cash-free Net Working Capital (DFCFNWC)	178	156	164	145	166	189	348	441	412	447	531
Debt-free Net Working Capital (DFNWC)	588	520	510	514	745	789	612	688	657	747	756
Net Working Capital (NWC)	588	520	510	514	745	789	606	681	651	740	609
Net Nonoperating Expense (NNE)	-13	-1.36	-4.68	-8.03	-6.36	9.72	-0.15	72	55	53	30
Net Nonoperating Obligations (NNO)	-104	-40	-33	-73	1,127	1,105	1,869	1,868	1,775	1,688	1,718
Total Depreciation and Amortization (D&A)	95	94	105	98	101	101	159	181	190	183	182
Debt-free, Cash-free Net Working Capital to Revenue	6.19%	5.52%	5.98%	5.34%	6.02%	6.87%	11.28%	12.86%	10.99%	10.95%	13.27%
Debt-free Net Working Capital to Revenue	20.46%	18.36%	18.55%	18.86%	27.03%	28.62%	19.85%	20.06%	17.55%	18.29%	18.88%
Net Working Capital to Revenue	20.46%	18.36%	18.55%	18.86%	27.03%	28.62%	19.63%	19.86%	17.37%	18.12%	15.23%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.78	$0.95	$0.85	$0.89	$0.74	$0.55	$0.01	($1.64)	($0.58)	($0.98)	($0.59)
Adjusted Weighted Average Basic Shares Outstanding	102.45M	99.14M	98.77M	98.75M	98.86M	98.87M	99.36M	99.42M	99.27M	99.54M	99.88M
Adjusted Diluted Earnings per Share	$0.77	$0.94	$0.84	$0.88	$0.77	$0.54	$0.01	($1.64)	($0.57)	($0.98)	($0.59)
Adjusted Weighted Average Diluted Shares Outstanding	102.85M	99.63M	99.05M	99.01M	99.07M	99.16M	99.38M	99.42M	99.27M	99.54M	99.88M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	99.43M	98.83M	98.72M	98.76M	98.76M	99.38M	99.42M	99.44M	98.45M	99.85M	99.93M
Normalized Net Operating Profit after Tax (NOPAT)	70	92	82	83	71	73	51	42	8.38	35	-4.55
Normalized NOPAT Margin	10.66%	13.58%	11.91%	11.84%	10.19%	10.81%	5.03%	4.01%	0.83%	3.45%	-0.49%
Pre Tax Income Margin	17.09%	18.50%	17.01%	17.54%	16.77%	11.28%	4.37%	-12.77%	-6.14%	-8.23%	-4.99%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	23.83	28.12	26.04	26.39	6.61	4.05	1.33	-3.64	-0.04	-2.41	-1.44
NOPAT to Interest Expense	14.79	21.46	18.81	18.60	4.29	2.89	0.10	-3.07	-0.01	-1.64	-1.00
EBIT Less CapEx to Interest Expense	-0.60	-0.36	0.39	-1.31	0.74	-0.18	-3.78	-6.66	-1.94	-4.62	-3.46
NOPAT Less CapEx to Interest Expense	-9.64	-7.01	-6.85	-9.10	-1.59	-1.34	-5.01	-6.09	-1.92	-3.85	-3.02
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	46.41%	44.43%	51.82%	50.62%	48.95%	49.77%	60.57%	-463.83%	-72.60%	-39.83%	-33.73%
Augmented Payout Ratio	103.36%	103.56%	95.32%	65.43%	63.85%	51.07%	60.57%	-463.83%	-72.60%	-39.83%	-33.73%

Financials Breakdown Chart

Key Financial Trends

Here are concise takeaways on Helmerich & Payne (NYSE: HP) based on the latest four years of quarterly cash flow, income statement, and balance sheet data provided. This focuses on trends useful to retail investors evaluating liquidity, profitability, and leverage.

Operating cash flow remained positive in the latest quarter: Net cash from continuing operating activities = $182,429,000 in Q1 2026.
Cash and equivalents increased modestly in the latest quarter: Net change in cash & equivalents = $53,608,000; ending cash around $247,195,000.
Revenue trend shows stability around the $1.0 billion level: Q1 2026 operating revenue = $1,017,026,000; recent quarters near $1.01–$1.04 billion (Q4 2025: $1,011,748,000; Q3 2025: $1,040,924,000).
Non-cash items are substantial and support reported cash flow: Depreciation = $181,919,000; Amortization = $1,250,000; Non-Cash Adjustments To Reconcile Net Income = $104,905,000 in Q1 2026.
Short-term liquidity remains comfortable: Total current assets ≈ $1.462B vs. Total current liabilities ≈ $0.722B, giving a rough current ratio near 2.0.
Capital expenditure activity indicates ongoing asset investment: Purchase of property, plant & equipment = -$67,565,000 in Q1 2026 (cash outflow).
Investing activities show net cash used for asset purchases and portfolio movements: Net cash from continuing investing activities = -$58,293,000.
Financing activities reflect cash outflows for debt service and distributions: Net cash from continuing financing activities = -$69,788,000.
Net income remains negative in the latest quarter: Consolidated net income = -$94,931,000 (Q1 2026).
Earnings per share are negative in the latest quarter: Basic EPS = -$0.98, Diluted EPS = -$0.98 (Q1 2026).
Leverage remains notable: Long-term debt ≈ $2.026B, Total liabilities ≈ $3.756B, Total equity ≈ $2.603B (as of Q1 2026). This yields a leveraged capital structure that warrants close monitoring.

05/26/26 03:12 AM ETAI Generated. May Contain Errors.

Helmerich & Payne Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Helmerich & Payne's fiscal year ends in September. Their fiscal year 2025 ended on September 30, 2025.

Helmerich & Payne's net income appears to be on a downward trend, with a most recent value of -$159.95 million in 2025, falling from $420.43 million in 2015. The previous period was $344.17 million in 2024. View Helmerich & Payne's forecast to see where analysts expect Helmerich & Payne to go next.

Helmerich & Payne's total operating income in 2025 was $3.32 million, based on the following breakdown:

Total Gross Profit: $1.18 billion
Total Operating Expenses: $1.18 billion

Over the last 10 years, Helmerich & Payne's total revenue changed from $3.16 billion in 2015 to $3.75 billion in 2025, a change of 18.5%.

Helmerich & Payne's total liabilities were at $3.88 billion at the end of 2025, a 35.3% increase from 2024, and a 72.2% increase since 2015.

In the past 10 years, Helmerich & Payne's cash and equivalents has ranged from $196.85 million in 2025 to $917.53 million in 2021, and is currently $196.85 million as of their latest financial filing in 2025.

Over the last 10 years, Helmerich & Payne's book value per share changed from 45.44 in 2015 to 27.40 in 2025, a change of -39.7%.

Related Companies

Financial statements for NYSE:HP last updated on 5/8/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Helmerich & Payne (HP) Financials

Financials Breakdown Chart

Key Financial Trends

Helmerich & Payne Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Helmerich & Payne (HP) Financials

Annual Income Statements for Helmerich & Payne

Quarterly Income Statements for Helmerich & Payne

Annual Cash Flow Statements for Helmerich & Payne

Quarterly Cash Flow Statements for Helmerich & Payne

Annual Balance Sheets for Helmerich & Payne

Quarterly Balance Sheets for Helmerich & Payne

Annual Metrics And Ratios for Helmerich & Payne

Quarterly Metrics And Ratios for Helmerich & Payne

Financials Breakdown Chart

Key Financial Trends

Helmerich & Payne Financials - Frequently Asked Questions

When does Helmerich & Payne's financial year end?

How has Helmerich & Payne's net income changed over the last 10 years?

What is Helmerich & Payne's operating income?

How has Helmerich & Payne's revenue changed over the last 10 years?

How much debt does Helmerich & Payne have?

How much cash does Helmerich & Payne have?

How has Helmerich & Payne's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools